A formal Phase 2 trial was completed in 2009, but over 15 years later, the results have never been published, another major red flag suggesting it failed to prove effective or safe
The two treatments operate through completely separate mechanisms: semaglutide acts on GLP-1 receptors in pancreatic, gastrointestinal, and central nervous system tissues, whilst botulinum toxin blocks acetylcholine release at peripheral nerve terminals
Many see great benefits initially, but soon become accustomed to the drug and find that their weight loss plateaus
What I tell my patients at Magnolia is that the peptide works best inside a real plan with proper rehab and nutrition, and we track your progress rather than chase a magic number
Post-hypoxic myoclonus in rodents, in Movement disorders (Elsevier), 681688